Global Hydroxyprogesterone Caproate Injection Market Research Report 2023(Status and Outlook)

Global Hydroxyprogesterone Caproate Injection Market Research Report 2023(Status and Outlook)



Report Overview

Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.

Global hydroxyprogesterone caproate injection main manufactuers include AMAG Pharmaceuticals, Mcguff Pharmaceuticals and Aspen, etc., totally holding a share for 97% of the market. North America is the largest market of hydroxyprogesterone caproate injection, with a share about 37%. As for the types of products, it can be divided into 1 ml injection(including 1.1 mL) and 5 ml injection. The most common product is 5 ml injection, with a share over 52%. In terms of applications, it is widely used in hospitals and clinics. The most commom application is in hospitals, with a share over 50%.

The Global Hydroxyprogesterone Caproate Injection Market Size was estimated at USD 259.00 million in 2022 and is projected to reach USD 287.45 million by 2029, exhibiting a CAGR of 1.50% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Hydroxyprogesterone Caproate Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hydroxyprogesterone Caproate Injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hydroxyprogesterone Caproate Injection market in any manner.

Global Hydroxyprogesterone Caproate Injection Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

AMAG Pharmaceuticals

Mcguff Pharmaceuticals Inc

Aspen Oss B.V

American Regent, Inc.

Mylan Institutional

Market Segmentation (by Type)

1 mL Injection(Including 1.1 mL)

5 mL Injection

Market Segmentation (by Application)

Hospitals

Academic Institutes

Independent Diagnostic Centres/Clinics

Blood Banks

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Hydroxyprogesterone Caproate Injection Market

Overview of the regional outlook of the Hydroxyprogesterone Caproate Injection Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Hydroxyprogesterone Caproate Injection
1.2 Key Market Segments
1.2.1 Hydroxyprogesterone Caproate Injection Segment by Type
1.2.2 Hydroxyprogesterone Caproate Injection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Hydroxyprogesterone Caproate Injection Market Overview
2.1 Global Market Overview
2.1.1 Global Hydroxyprogesterone Caproate Injection Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Hydroxyprogesterone Caproate Injection Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Hydroxyprogesterone Caproate Injection Market Competitive Landscape
3.1 Global Hydroxyprogesterone Caproate Injection Sales by Manufacturers (2018-2023)
3.2 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Manufacturers (2018-2023)
3.3 Hydroxyprogesterone Caproate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hydroxyprogesterone Caproate Injection Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Hydroxyprogesterone Caproate Injection Sales Sites, Area Served, Product Type
3.6 Hydroxyprogesterone Caproate Injection Market Competitive Situation and Trends
3.6.1 Hydroxyprogesterone Caproate Injection Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hydroxyprogesterone Caproate Injection Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Hydroxyprogesterone Caproate Injection Industry Chain Analysis
4.1 Hydroxyprogesterone Caproate Injection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Hydroxyprogesterone Caproate Injection Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Hydroxyprogesterone Caproate Injection Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2018-2023)
6.3 Global Hydroxyprogesterone Caproate Injection Market Size Market Share by Type (2018-2023)
6.4 Global Hydroxyprogesterone Caproate Injection Price by Type (2018-2023)
7 Hydroxyprogesterone Caproate Injection Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hydroxyprogesterone Caproate Injection Market Sales by Application (2018-2023)
7.3 Global Hydroxyprogesterone Caproate Injection Market Size (M USD) by Application (2018-2023)
7.4 Global Hydroxyprogesterone Caproate Injection Sales Growth Rate by Application (2018-2023)
8 Hydroxyprogesterone Caproate Injection Market Segmentation by Region
8.1 Global Hydroxyprogesterone Caproate Injection Sales by Region
8.1.1 Global Hydroxyprogesterone Caproate Injection Sales by Region
8.1.2 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Region
8.2 North America
8.2.1 North America Hydroxyprogesterone Caproate Injection Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hydroxyprogesterone Caproate Injection Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hydroxyprogesterone Caproate Injection Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hydroxyprogesterone Caproate Injection Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 AMAG Pharmaceuticals
9.1.1 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Basic Information
9.1.2 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product Overview
9.1.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product Market Performance
9.1.4 AMAG Pharmaceuticals Business Overview
9.1.5 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection SWOT Analysis
9.1.6 AMAG Pharmaceuticals Recent Developments
9.2 Mcguff Pharmaceuticals Inc
9.2.1 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Basic Information
9.2.2 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product Overview
9.2.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product Market Performance
9.2.4 Mcguff Pharmaceuticals Inc Business Overview
9.2.5 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection SWOT Analysis
9.2.6 Mcguff Pharmaceuticals Inc Recent Developments
9.3 Aspen Oss B.V
9.3.1 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Basic Information
9.3.2 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product Overview
9.3.3 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product Market Performance
9.3.4 Aspen Oss B.V Business Overview
9.3.5 Aspen Oss B.V Hydroxyprogesterone Caproate Injection SWOT Analysis
9.3.6 Aspen Oss B.V Recent Developments
9.4 American Regent, Inc.
9.4.1 American Regent, Inc. Hydroxyprogesterone Caproate Injection Basic Information
9.4.2 American Regent, Inc. Hydroxyprogesterone Caproate Injection Product Overview
9.4.3 American Regent, Inc. Hydroxyprogesterone Caproate Injection Product Market Performance
9.4.4 American Regent, Inc. Business Overview
9.4.5 American Regent, Inc. Hydroxyprogesterone Caproate Injection SWOT Analysis
9.4.6 American Regent, Inc. Recent Developments
9.5 Mylan Institutional
9.5.1 Mylan Institutional Hydroxyprogesterone Caproate Injection Basic Information
9.5.2 Mylan Institutional Hydroxyprogesterone Caproate Injection Product Overview
9.5.3 Mylan Institutional Hydroxyprogesterone Caproate Injection Product Market Performance
9.5.4 Mylan Institutional Business Overview
9.5.5 Mylan Institutional Hydroxyprogesterone Caproate Injection SWOT Analysis
9.5.6 Mylan Institutional Recent Developments
10 Hydroxyprogesterone Caproate Injection Market Forecast by Region
10.1 Global Hydroxyprogesterone Caproate Injection Market Size Forecast
10.2 Global Hydroxyprogesterone Caproate Injection Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hydroxyprogesterone Caproate Injection Market Size Forecast by Country
10.2.3 Asia Pacific Hydroxyprogesterone Caproate Injection Market Size Forecast by Region
10.2.4 South America Hydroxyprogesterone Caproate Injection Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hydroxyprogesterone Caproate Injection by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Hydroxyprogesterone Caproate Injection Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Hydroxyprogesterone Caproate Injection by Type (2024-2029)
11.1.2 Global Hydroxyprogesterone Caproate Injection Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Hydroxyprogesterone Caproate Injection by Type (2024-2029)
11.2 Global Hydroxyprogesterone Caproate Injection Market Forecast by Application (2024-2029)
11.2.1 Global Hydroxyprogesterone Caproate Injection Sales (K MT) Forecast by Application
11.2.2 Global Hydroxyprogesterone Caproate Injection Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings